1. |
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2024, 149(1): e1-e156.
|
2. |
Chen LW, Li QZ, Chen JY, et al. A new procedure for elimination of atrial fibrillation associated with mitral valve disease: a proof-of-concept study. Int J Surg, 2023, 109(10): 2914-2925.
|
3. |
Chang C, Zhang CJ, Zhao X, et al. Differential regulation of mitogen-activated protein kinase signaling pathways in human with different types of mitral valvular disease. J Surg Res, 2013, 181(1): 49-59.
|
4. |
Qian YJ, Meng J, Tang H, et al. Different structural remodeling in atrial fibrillation with different types of mitral valvular diseases. Europace, 2010, 12(3): 371-377.
|
5. |
Beyer C, Tokarska L, Stühlinger M, et al. Structural cardiac remodeling in atrial fibrillation. JACC Cardiovasc Imaging, 2021, 14(11): 2199-2208.
|
6. |
Molnár AÁ, Sánta A, Pásztor DT, et al. Atrial cardiomyopathy in valvular heart disease: from molecular biology to clinical perspectives. Cells, 2023, 12(13): 1796.
|
7. |
Deng ZQ, Fan T, Xiao C, et al. TGF-β signaling in health, disease, and therapeutics. Signal Transduct Target Ther, 2024, 9(1): 61.
|
8. |
Zhu EY, Liu Y, Zhong M, et al. Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease. Front Immunol, 2023, 14: 1142240.
|
9. |
Xie SY, Song SC, Liu SR, et al. (Pro)renin receptor mediates tubular epithelial cell pyroptosis in diabetic kidney disease via DPP4-JNK pathway. J Transl Med, 2024, 22(1): 26.
|
10. |
Gehi BR, Gadhave K, Uversky VN, et al. Intrinsic disorder in proteins associated with oxidative stress-induced JNK signaling. Cell Mol Life Sci, 2022, 79(4): 202.
|
11. |
Nadel G, Maik-Rachline G, Seger R. JNK cascade-induced apoptosis-a unique role in GqPCR signaling. Int J Mol Sci, 2023, 24(17): 13527.
|
12. |
Nikolic I, Leiva M, Sabio G. The role of stress kinases in metabolic disease. Nat Rev Endocrinol, 2020, 16(12): 697-716.
|
13. |
Babapoor-Farrokhran S, Tarighati Rasekhi R, Gill D, et al. How transforming growth factor contributes to atrial fibrillation? Life Sci, 2021, 266: 118823.
|
14. |
Luo B, Zheng R, Shi CQ, et al. DACT2 modulates atrial fibrillation through TGF/β and Wnt signaling pathways. Heliyon, 2024, 10(16): e36050.
|
15. |
Song ZP, Song HX, Liu D, et al. Overexpression of MFN2 alleviates sorafenib-induced cardiomyocyte necroptosis via the MAM-CaMKIIδ pathway in vitro and in vivo. Theranostics, 2022, 12(3): 1267-1285.
|
16. |
Ploeg MC, Munts C, Prinzen FW, et al. Piezo1 mechanosensitive ion channel mediates stretch-induced Nppb expression in adult rat cardiac fibroblasts. Cell, 2021, 10(7): 1745.
|
17. |
Jakob D, Klesen A, Allegrini B, et al. Piezo1 and BKCa channels in human atrial fibroblasts: interplay and remodelling in atrial fibrillation. J Mol Cell Cardiol, 2021, 158: 49-62.
|
18. |
Frangogiannis NG. Transforming growth factor-β in myocardial disease. Nat Rev Cardiol. 2022, 19(7): 435-455.
|
19. |
Lodyga M, Hinz B. TGF-β1: a truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol, 2020, 101: 123-139.
|
20. |
Chen J, Ye C, Wan C, et al. The roles of c-Jun N-Terminal kinase (JNK) in infectious diseases. Int J Mol Sci, 2021, 22(17): 9640.
|
21. |
Plotnikov MB, Cherrnysheva GA, Smol'yakova VI, et al. Cardioprotective effects of a selective c-Jun N-terminal kinase inhibitor in a rat model of myocardial infarction. Biomedicines, 2023, 11(3): 714.
|
22. |
Duan YL, Cheng SY, Jia L, et al. PDRPS7 protects cardiac cells from hypoxia/reoxygenation injury through inactivation of JNKs. FEBS Open Bio, 2020, 10(4): 593-606.
|
23. |
Zhang Y, Yuan M, Cai WB, et al. Prostaglandin I2 signaling prevents angiotensin Ⅱ-induced atrial remodeling and vulnerability to atrial fibrillation in mice. Cell Mol Life Sci, 2024, 81(1): 264.
|
24. |
Shine M, Gordon J, Schärfen L, et al. Co-transcriptional gene regulation in eukaryotes and prokaryotes. Nat Rev Mol Cell Biol, 2024, 25(7): 534-554.
|
25. |
Xie WJ, Liu M, Zhang X, et al. Astaxanthin suppresses LPS-induced myocardial apoptosis by regulating PTP1B/JNK pathway in vitro. Int Immunopharmacol, 2024, 127: 111395.
|
26. |
Ibrahim KA, Abdelgaid HA, Eleyan M, et al. Resveratrol alleviates cardiac apoptosis following exposure to fenitrothion by modulating the sirtuin1/c-Jun N-terminal kinases/p53 pathway through pro-oxidant and inflammatory response improvements: in vivo and in silico studies. Life Sci, 2022, 290: 120265.
|
27. |
Tkachenko A. Apoptosis and eryptosis: similarities and differences. Apoptosis, 2024, 29(3-4): 482-502.
|
28. |
Newton K, Strasser A, Kayagaki N, et al. Cell death. Cell, 2024, 187(2): 235-256.
|
29. |
Hu N, Sun M, Lv N, et al. ROS-suppression nanoplatform combined activation of STAT3/Bcl-2 pathway for preventing myocardial infarction in mice. ACS Appl Mater Interfaces, 2024, 16(10): 12188-12201.
|